Przerost lewej komory serca
Leczenie
Leczenie przerostu lewej komory serca (PLKS) wymaga indywidualizacji terapii w zależności od etiologii, z naciskiem na farmakoterapię, modyfikację stylu życia oraz interwencje zabiegowe. W przypadku nadciśnienia tętniczego, podstawę stanowią inhibitory ACE (np. enalapril, lisinopril), blokery receptora angiotensyny II (losartan, valsartan), blokery kanału wapniowego (amlodypina, werapamil, diltiazem), diuretyki tiazydopodobne (chlortalidon, hydrochlorotiazyd) oraz beta-blokery (metoprolol, bisoprolol, karwedilol). Inhibitory SGLT2 (dapagliflozyna, empagliflozyna) wykazują dodatkowe korzyści w redukcji masy ciała i obniżeniu ciśnienia tętniczego. W kardiomiopatii przerostowej (HCM) stosuje się beta-blokery, niedihydropirydynowe blokery kanału wapniowego, dizopirymid oraz nowoczesny lek mavacamten, alosteryczny inhibitor miozyny sercowej, zatwierdzony dla pacjentów z objawową zawężającą HCM klasy II-III wg NYHA. Wskazane jest także leczenie chorób współistniejących, takich jak cukrzyca, choroby tarczycy, amyloidoza czy choroba Fabry’ego, z uwzględnieniem enzymatycznej terapii zastępczej (ERT) w tej ostatniej.
Leczenie przerostu lewej komory serca
Leczenie przerostu lewej komory serca (PLKS) zależy przede wszystkim od przyczyny, która go wywołała. Kompleksowe podejście do terapii PLKS obejmuje farmakoterapię, zmiany stylu życia, a w wybranych przypadkach postępowanie zabiegowe. Wczesne rozpoczęcie leczenia umożliwia zahamowanie lub nawet cofnięcie zmian strukturalnych w mięśniu sercowym, co może znacząco poprawić rokowanie pacjenta.12
Farmakoterapia PLKS
Leki przeciwnadciśnieniowe stanowią podstawę terapii przerostu lewej komory w przypadkach, gdy przyczyną jest nadciśnienie tętnicze. Właściwe dobranie leków pozwala nie tylko na kontrolę ciśnienia tętniczego, ale również na odwrócenie lub zahamowanie procesu przerostu mięśnia sercowego.34
Do najczęściej stosowanych grup leków w terapii PLKS należą:
- Inhibitory konwertazy angiotensyny (ACE-I) – poszerzają naczynia krwionośne obniżając ciśnienie tętnicze, poprawiają przepływ krwi i zmniejszają obciążenie serca. Mogą powodować uporczywy kaszel jako działanie niepożądane.56
- Blokery receptora angiotensyny II (ARB) – wykazują korzystny wpływ na regresję przerostu mięśnia lewej komory, co potwierdzono w badaniu LIFE.78
- Blokery kanału wapniowego – szczególnie przydatne u pacjentów z PLKS, którzy mają prawidłową funkcję skurczową i zaburzenia podatności rozkurczowej.910
- Diuretyki – zwłaszcza diuretyki tiazydopodobne, jak chlortalidon, które wykazują skuteczność w regresji przerostu mięśnia lewej komory.1112
- Beta-blokery – szczególnie zalecane u osób starszych ze znacznie pogrubiałymi ścianami lewej komory i małą objętością jamy, co wiąże się z hiperkinetyczną funkcją skurczową.1314
- Inhibitory SGLT2 – stosunkowo nowa grupa leków przeciwcukrzycowych, które wykazują dodatkowe korzyści w postaci obniżenia ciśnienia tętniczego i redukcji masy ciała, co może wpływać korzystnie na regresję PLKS.1516
W przypadku kardiomiopatii przerostowej (HCM), która stanowi specyficzną formę przerostu lewej komory, stosuje się:
- Beta-blokery – leki pierwszego wyboru zarówno w postaci zawężającej, jak i niezawężającej objawowej HCM.1718
- Niedihydropirydynowe blokery kanału wapniowego – zalecane u pacjentów z HCM, którzy nie odpowiadają na leczenie beta-blokerami lub mają przeciwwskazania do ich stosowania.19
- Dizopirymid – lek antyarytmiczny klasy Ia, zalecany u pacjentów z zawężającą HCM, którzy pozostają objawowi pomimo stosowania beta-blokerów i blokerów kanału wapniowego.20
- Mavacamten – pierwszy w swojej klasie alosteryczny inhibitor miozyny sercowej, zatwierdzony przez FDA dla dorosłych z objawową zawężającą kardiomiopatią przerostową klasy II-III wg NYHA w celu poprawy wydolności wysiłkowej i złagodzenia objawów.21
Leczenie zabiegowe
W przypadkach, gdy przyczyną przerostu lewej komory serca jest stenoza zastawki aortalnej lub inna wada zastawkowa, często niezbędne jest leczenie zabiegowe.2223
Do głównych metod zabiegowych należą:
- Operacja wymiany lub naprawy zastawki aortalnej – w przypadku stenozy aortalnej zabieg operacyjny pozwala na przywrócenie prawidłowego przepływu krwi, co prowadzi do regresji przerostu lewej komory, poprawy funkcji skurczowej i rozkurczowej oraz złagodzenia objawów niewydolności serca.2425
- Miektomia przegrody międzykomorowej – zabieg wykonywany u pacjentów z ciężkimi objawami kardiomiopatii przerostowej opornej na leczenie i z gradientem w drodze odpływu przekraczającym 50 mmHg. Polega na usunięciu fragmentu pogrubiałej przegrody międzykomorowej, co poszerza drogę odpływu lewej komory.2627
- Przezskórna ablacja alkoholowa przegrody – małoinwazyjna alternatywa dla miektomii, polegająca na selektywnym podaniu alkoholu etylowego do gałęzi tętnic przegrodowych, co prowadzi do kontrolowanej martwicy tkanki mięśniowej przegrody. Metoda ta oferuje krótszy czas rekonwalescencji i mniejszy dyskomfort dla pacjenta w porównaniu z zabiegiem chirurgicznym.2829
- Wszczepienie kardiowertera-defibrylatora (ICD) – zalecane u pacjentów z PLKS wysokiego ryzyka nagłego zgonu sercowego, szczególnie w przebiegu kardiomiopatii przerostowej. ICD skutecznie przerywa groźne dla życia arytmie komorowe.3031
- Wszczepienie stymulatora serca – proponowane leczenie dla wybranych pacjentów z kardiomiopatią przerostową. Stymulacja wierzchołka prawej komory z zachowaniem synchronii przedsionkowo-komorowej może prowadzić do zmniejszenia gradientu w drodze odpływu lewej komory oraz poprawy objawów i jakości życia.32
- Transplantacja serca – zalecana w określonych sytuacjach u pacjentów z zaawansowaną chorobą serca i objawami niewydolności serca klasy III lub IV według NYHA, opornymi na wszystkie inne interwencje.33
Modyfikacje stylu życia
Zmiany stylu życia stanowią istotny element terapii przerostu lewej komory serca, szczególnie gdy przyczyną jest nadciśnienie tętnicze.3435
Kluczowe modyfikacje stylu życia obejmują:
- Regularna aktywność fizyczna – zaleca się co najmniej 150 minut umiarkowanej aktywności aerobowej tygodniowo.36
- Dieta o niskiej zawartości sodu – ograniczenie spożycia soli pomaga w kontroli ciśnienia tętniczego. Badania pokazują, że pacjenci ze słabym przestrzeganiem zaleceń dotyczących ograniczenia soli mają ponad 8-krotnie większe ryzyko niekontrolowanego nadciśnienia.37
- Zbilansowana dieta – zaleca się stosowanie diety śródziemnomorskiej lub diety DASH (Dietary Approaches to Stop Hypertension).38
- Redukcja masy ciała – u osób z nadwagą lub otyłością, szczególnie otyłością brzuszną, która wiąże się ze zwiększonym ryzykiem PLKS.39
- Ograniczenie spożycia alkoholu – nadmierne spożycie alkoholu może podwyższać ciśnienie tętnicze.40
- Zarządzanie stresem – techniki redukcji stresu mogą pomóc w kontroli ciśnienia tętniczego.41
- Odpowiednia ilość snu – zaleca się 7-9 godzin snu każdej nocy.42
- Leczenie bezdechu sennego – jeśli występuje, może pomóc w obniżeniu ciśnienia tętniczego i odwróceniu przerostu lewej komory.43
Leczenie chorób współistniejących
Skuteczne leczenie chorób współistniejących jest istotnym elementem kompleksowego podejścia do terapii przerostu lewej komory serca.44
Najważniejsze aspekty to:
- Leczenie cukrzycy – kontrola glikemii może pomóc w redukcji ryzyka sercowo-naczyniowego.45
- Leczenie chorób tarczycy – zarówno niedoczynność, jak i nadczynność tarczycy mogą wpływać niekorzystnie na funkcję serca.46
- Terapia enzymatyczna w chorobie Fabry’ego – leczenie koncentruje się na zastąpieniu brakującego lub nieprawidłowego enzymu (alfa-galaktozydazy A) poprzez enzymatyczną terapię zastępczą (ERT) oraz leczenie różnych objawów i powikłań choroby.4748
- Leczenie amyloidozy – może obejmować farmakoterapię, chemioterapię i potencjalnie przeszczep komórek macierzystych.49
Monitorowanie i rokowanie
Regularne monitorowanie stanu pacjenta z przerostem lewej komory serca jest niezbędne dla oceny skuteczności leczenia i zapobiegania powikłaniom.50
Kluczowe elementy monitorowania obejmują:
- Regularne badania kardiologiczne – obejmujące szczegółową ocenę funkcji serca, co pozwala lekarzom na obserwację zmian w czasie.51
- Codzienne pomiary ciśnienia tętniczego – pozwalają na wczesne wykrycie zmian i dostosowanie leczenia.52
- Okresowe badania echokardiograficzne – umożliwiają ocenę regresji przerostu lewej komory. Należy jednak pamiętać, że potrzebne są znaczące zmiany w szacowanej masie lewej komory (około 60 g) w seryjnych badaniach u tego samego pacjenta, aby z pewnością stwierdzić, że masa lewej komory uległa zmniejszeniu.53
- Badania elektrokardiograficzne – pozwalają na monitorowanie zmian w zapisie EKG wskazujących na PLKS.54
Jeśli chodzi o rokowanie, pacjenci z przerostem lewej komory serca, który jest skutecznie leczony, mogą prowadzić normalne życie. W wielu przypadkach możliwa jest regresja przerostu, szczególnie gdy przyczyną było nadciśnienie tętnicze i zostało ono skutecznie kontrolowane.5556
Badania wykazały, że regresja PLKS związana z leczeniem nadciśnienia tętniczego zmniejsza ryzyko incydentów sercowo-naczyniowych i nagłego zgonu, sugerując, że cofnięcie się przerostu lewej komory może być markerem poprawy rokowania sercowo-naczyniowego, nawet u pacjentów w podeszłym wieku.57
Warto jednak zauważyć, że w niektórych przypadkach, mimo odpowiedniego leczenia, PLKS może postępować. Dotyczy to na przykład niektórych pacjentów z chorobą Fabry’ego, u których mimo długotrwałej enzymatycznej terapii zastępczej obserwuje się progresję wskaźnika masy lewej komory.5859
Nowe kierunki w leczeniu PLKS
Badania naukowe nad nowymi metodami leczenia przerostu lewej komory serca stale się rozwijają, dając nadzieję pacjentom potrzebującym bardziej skutecznych terapii.60
Do obiecujących kierunków należą:
- Inhibitory angiotensyny-neprylizyny – raportowano ich skuteczność w regresji przerostu.61
- Inhibitory SGLT2 – badania wykazują, że mogą zmniejszać masę lewej komory i ambulatoryjne ciśnienie tętnicze oraz poprawiać rokowanie u pacjentów z niewydolnością serca; jednak ich związek z poprawą PLKS wymaga dalszych badań.62
- Celowanie w zmiany transkrypcyjne indukowane stresem – nowa strategia terapeutyczna, która wymaga jednak lepszego zrozumienia, kiedy te zmiany transkrypcyjne rozpoczynają się i jak ich odwrócenie podczas stresu sercowego wpływa na odpowiedź.63
- Zastosowanie uczenia maszynowego – w diagnostyce PLKS może poprawić czułość w wykrywaniu przerostu lewej komory.64
Indywidualizacja leczenia
Indywidualizacja planu leczenia jest kluczowa dla osiągnięcia optymalnych wyników u pacjentów z przerostem lewej komory serca.6566
Czynniki wpływające na wybór terapii obejmują:
- Przyczynę przerostu lewej komory – różne etiologie wymagają różnych podejść terapeutycznych.67
- Nasilenie objawów – decyduje o intensywności leczenia i potrzebie interwencji zabiegowej.68
- Wiek pacjenta – beta-blokery mogą być szczególnie korzystne u osób starszych.69
- Choroby współistniejące – wpływają na wybór leków i innych form terapii.70
- Pochodzenie etniczne – osoby pochodzenia afroamerykańskiego mogą odnieść szczególne korzyści z diuretyków w leczeniu nadciśnienia i redukcji masy lewej komory.71
Najlepsze rezultaty osiąga się poprzez ścisłą współpracę pacjenta z zespołem medycznym, regularne wizyty kontrolne i dostosowywanie terapii do indywidualnych potrzeb i odpowiedzi na leczenie.7273
| Grupa leków | Przykłady | Główne wskazania w PLKS | Mechanizm działania |
|---|---|---|---|
| Inhibitory ACE | Enalapril, Lisinopril | Nadciśnienie tętnicze z PLKS | Rozszerzenie naczyń, poprawa przepływu krwi, zmniejszenie obciążenia serca |
| Blokery receptora angiotensyny (ARB) | Losartan, Valsartan | Nadciśnienie tętnicze z PLKS, nietolerancja ACE-I | Blokada receptora angiotensyny II, rozszerzenie naczyń |
| Blokery kanału wapniowego | Amlodypina, Werapamil, Diltiazem | Nadciśnienie tętnicze z PLKS, HCM | Blokada kanałów wapniowych, rozluźnienie mięśni naczyń, obniżenie ciśnienia |
| Diuretyki | Chlortalidon, Hydrochlorotiazyd | Nadciśnienie tętnicze z PLKS | Eliminacja nadmiaru sodu i wody, zmniejszenie objętości krwi |
| Beta-blokery | Metoprolol, Bisoprolol, Karwedilol | Nadciśnienie tętnicze z PLKS, HCM | Zmniejszenie częstości akcji serca, zmniejszenie siły skurczu |
| Inhibitory SGLT2 | Dapagliflozyna, Empagliflozyna | Cukrzyca z PLKS, niewydolność serca z PLKS | Zwiększenie wydalania glukozy z moczem, obniżenie ciśnienia, redukcja masy ciała |
| Leki przeciwarytmiczne | Dizopirymid, Amiodaron | HCM z arytmiami | Stabilizacja rytmu serca, zapobieganie arytmiom |
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
Determining the etiologies of left ventricular hypertrophy (LVH) can be challenging due to the similarities of the different manifestations in clinical presentation and morphological features. […] Management of LVH involves lifestyle changes, medications, surgery, and implantable devices. […] Treatment involves lifestyle changes (including weight reduction and exercise) and, depending upon the cause, may include medications, surgery, and implantable devices for the prevention of sudden cardiac death. […] Lowering the blood pressure with antihypertensive agents decreases cardiac mass in patients with LVH, and weight loss or dietary sodium restriction have additional beneficial effects on the improvement in cardiac mass. […] Numerous treatment strategies, ranging from thiazide diuretics, renin-angiotensinaldosterone system (RAAS) inhibitors and calcium channel blockers (CCBs) to sodium-glucose cotransporter type-2 (SGLT2) inhibitors have been shown to regress LVH.
- #2 Left ventricular hypertrophy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/diagnosis-treatment/drc-20374319
Treatment for left ventricular hypertrophy depends on the cause. It may include medicines, catheter procedures or surgery. It’s important to manage conditions such as high blood pressure and sleep apnea, which can cause blood pressure to be higher. […] Medicines are used to treat symptoms and prevent complications of left ventricular hypertrophy. Blood pressure medicines may help reduce or prevent thickening of the heart muscle. The type of medicine used depends on the cause of left ventricular hypertrophy. […] Medicines that might be used to treat left ventricular hypertrophy or the conditions that cause it include: Angiotensin-converting enzyme inhibitors. Also called ACE inhibitors, these medicines widen blood vessels to lower blood pressure. They can improve blood flow and decrease the strain on the heart. Side effects include a persistent cough.
- #3 Left Ventricular Hypertrophy (LVH)https://my.clevelandclinic.org/health/diseases/21883-left-ventricular-hypertrophy
Treating the cause of LVH will help stop or slow disease progression. Depending on the cause, you may need to change your daily habits, take medicine or have surgery. […] Left ventricular hypertrophy treatment may include: […] Lifestyle changes. Heart-healthy habits can lower your blood pressure and reduce LVH complications. Good habits include eating healthy foods and being physically active. […] Blood pressure medication. Lowering your blood pressure will help prevent left ventricular hypertrophy from worsening. It also can reduce your risk of heart failure, heart attack or stroke. […] Other medicines. An SGLT2 inhibitor (an oral diabetes medicine) or allopurinol can help manage LVH. […] Heart valve surgery. If aortic valve stenosis caused your condition, you may need aortic valve surgery to replace the narrowed valve. This allows blood to flow properly.
- #4 Left ventricular hypertrophy – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/symptoms-causes/syc-20374314
Treatment of left ventricular hypertrophy depends on the cause. Treatment may include medications or surgery. […] Treating high blood pressure can help reduce left ventricular hypertrophy symptoms and may even reverse it.
- #5 Left ventricular hypertrophy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/diagnosis-treatment/drc-20374319
Treatment for left ventricular hypertrophy depends on the cause. It may include medicines, catheter procedures or surgery. It’s important to manage conditions such as high blood pressure and sleep apnea, which can cause blood pressure to be higher. […] Medicines are used to treat symptoms and prevent complications of left ventricular hypertrophy. Blood pressure medicines may help reduce or prevent thickening of the heart muscle. The type of medicine used depends on the cause of left ventricular hypertrophy. […] Medicines that might be used to treat left ventricular hypertrophy or the conditions that cause it include: Angiotensin-converting enzyme inhibitors. Also called ACE inhibitors, these medicines widen blood vessels to lower blood pressure. They can improve blood flow and decrease the strain on the heart. Side effects include a persistent cough.
- #6 Left ventricular hypertrophy // Middlesex Healthhttps://middlesexhealth.org/learning-center/diseases-and-conditions/left-ventricular-hypertrophy
Treatment of left ventricular hypertrophy depends on the cause. Treatment may include medications or surgery. […] Treatment for left ventricular hypertrophy depends on the underlying cause. It may include medications, catheter procedures or surgery. It’s important to manage conditions such as high blood pressure and sleep apnea, which can cause blood pressure to be higher. […] Medicines are used to treat symptoms and prevent complications of left ventricular hypertrophy. Blood pressure drugs may help reduce or prevent thickening of the heart muscle. The type of medication prescribed depends on the cause of left ventricular hypertrophy. […] Medications that might be used to treat left ventricular hypertrophy or the conditions that cause it include: Angiotensin-converting enzyme inhibitors. Also called ACE inhibitors, these medications widen blood vessels to lower blood pressure. They can improve blood flow and decrease the strain on the heart. Side effects include a persistent cough. […] Left ventricular hypertrophy that is caused by aortic valve stenosis might require a catheter procedure or surgery to repair or replace the valve. […] Surgery may be done if the condition causes heart failure symptoms or a blockage that interferes with the heart’s pumping action.
- #7 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
Starting early treatment while providing the appropriate target blood pressure prevents irreversible LVH. […] Apart from LIFE study, different angiotensin II receptor blockers (ARBs) have shown comparable benefit over beta adrenergic blockers. […] SGLT2 inhibitors are relatively novel antidiabetic agents with added benefits in terms of blood pressure and weight reduction. […] The association of LVH with increased cardiovascular morbidity and mortality demands aggressive treatment. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications.
- #8 Treatment of hypertension in association with left ventricular hypertrophy – Hypertension Canada | For Healthcare Professionalshttps://hypertension.ca/guidelines/prevention-treatment/hypertension-with-hypertrophy
Hypertensive patients with left ventricular hypertrophy should be treated with antihypertensive therapy to decrease the rate of subsequent cardiovascular events (Grade C). […] The choice of initial therapy can be influenced by the presence of left ventricular hypertrophy (Grade D). Initial therapy can be drug treatment using ACE inhibitors, ARBs, long-acting CCBs, or thiazide/thiazide-like diuretics. […] Pharmacotherapy with the additional use of spironolactone, bisoprolol, doxazosin, amiloride, eplerenone, or clonidine with the baseline regimen decreases BP significantly, with the greatest BP-lowering shown with spironolactone.
- #9https://link.springer.com/article/10.1007/s11936-999-0038-0
The use of ACE inhibitors is increasing. Unfortunately, the cost of these agents is higher than that of some other classes of agents, such as diuretics, which show excellent evidence of regression of hypertrophy. African-American and elderly persons, in particular, may benefit from diuretics for treatment of hypertension as well as reduction of left ventricular (LV) mass. […] Beta-blockers should be considered in the elderly, especially those with greatly thickened LV walls and small chamber sizes, factors associated with hyperdynamic systolic performance, systolic midcavity obliteration, and diastolic relaxation abnormalities on echocardiography. […] Calcium channel blockers may also be useful in patients with LVH who have normal systolic performance and diastolic compliance abnormalities.
- #10 Management of the patient with left ventricular hypertrophy – PubMedhttps://pubmed.ncbi.nlm.nih.gov/7690320/
The management of left ventricular hypertrophy (LVH) presupposes that the patient is identified by echocardiography and is carefully evaluated for risk stratification, taking into consideration possible associated complications. […] The role of non-pharmacological treatment is limited, except in obese patients. Drug treatment, especially using calcium antagonists, angiotensin converting enzyme inhibitors and beta-blockers, has proved to be effective in reducing LVH. […] These drugs are also effective in controlling, if not reversing, the associated pathophysiological changes and complications, such as impaired systolic and diastolic function, and ventricular arrhythmias. […] The desirable goal is LVH regression, but it may not be achievable in over 50% of patients, and it is not possible to identify patients in whom regression is likely.
- #11 Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence | Clinical Hypertension | Full Texthttps://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-019-0131-y
We have read with interest the Korean Society of Hypertension guidelines for the management of hypertension and congratulate the Society for an extensive review of literature while drafting the guidelines. The guidelines indicate preferring ACE-I and CCB over diuretics in patients with left ventricle hypertrophy. However, in landmark head-to-head comparison trials, the thiazide-like diuretic chlorthalidone has been shown to be superior to ACE-I and CCB in decreasing left ventricle mass and preventing heart failure in hypertensive patients. […] The Treatment of Mild Hypertension Study (TOMHS) assessed the effect of five antihypertensive monotherapies (CTD, acebutolol, doxazosin, amlodipine and enalapril) on reduction of LVM in 902 patients with mild (stage 1) hypertension. After 4 years of treatment, all 5 therapies showed reduction in LVM from baseline; but only CTD declined LVM significantly more than placebo.
- #12 Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence | Clinical Hypertension | Full Texthttps://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-019-0131-y
ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), the largest randomized hypertension outcomes trial, provides another head-to-head comparison between CTD, ACE-I lisinopril and the CCB amlodipine. After a mean follow-up of almost 5 years, although there was no difference between treatments on the primary outcome (combined fatal CHD or nonfatal myocardial infarction), the most intriguing finding of ALLHAT has been the significantly lower rates of HF events in the CTD group compared to both CCB and ACE-I. […] The direct cardiac effect of LVH includes an increased risk of developing congestive heart failure and the associated morbidity and mortality. Thus, one of the major objectives in achieving regression of LVH and reduction of LV mass is to reduce the incidence of HFpEF and HFrEF and the allied hospitalisations and death. However, reduction in LVH may not always translate into direct reduction in incidence of diastolic dysfunction and HF.
- #13https://link.springer.com/article/10.1007/s11936-999-0038-0
The use of ACE inhibitors is increasing. Unfortunately, the cost of these agents is higher than that of some other classes of agents, such as diuretics, which show excellent evidence of regression of hypertrophy. African-American and elderly persons, in particular, may benefit from diuretics for treatment of hypertension as well as reduction of left ventricular (LV) mass. […] Beta-blockers should be considered in the elderly, especially those with greatly thickened LV walls and small chamber sizes, factors associated with hyperdynamic systolic performance, systolic midcavity obliteration, and diastolic relaxation abnormalities on echocardiography. […] Calcium channel blockers may also be useful in patients with LVH who have normal systolic performance and diastolic compliance abnormalities.
- #14 Mastering Left Ventricular Hypertrophy: Guide for Nursing Studentshttps://simplenursing.com/left-ventricular-hypertrophy/
Patients with LVH are most at risk for cardiovascular fatalities. This is why LVH treatment should be vigorous and started as soon as possible. […] In the long-term, LVH can be avoided with lifestyle changes that lower blood pressure, mainly with the right foods and exercise. […] While in a hospital, you need to administer IV solutions to the LVH patient while keeping the overall dosage below the limits. It is important to keep a close eye on the fluid administration rate. An important thing to note is not to use saline solutions on patients with LVH. […] In addition to antihypertensive medications, youâll need to administer medications that remove excess fluid, like diuretics â or slow down heart rate, like beta blockers. […] The patient might not be able to tolerate an increase in fluid volume because of their already elevated left ventricular pressure (preload). […] An important thing to note is not to use saline solutions on patients with LVH.
- #15 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
Starting early treatment while providing the appropriate target blood pressure prevents irreversible LVH. […] Apart from LIFE study, different angiotensin II receptor blockers (ARBs) have shown comparable benefit over beta adrenergic blockers. […] SGLT2 inhibitors are relatively novel antidiabetic agents with added benefits in terms of blood pressure and weight reduction. […] The association of LVH with increased cardiovascular morbidity and mortality demands aggressive treatment. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications.
- #16 Left Ventricular Hypertrophy (LVH)https://my.clevelandclinic.org/health/diseases/21883-left-ventricular-hypertrophy
Treating the cause of LVH will help stop or slow disease progression. Depending on the cause, you may need to change your daily habits, take medicine or have surgery. […] Left ventricular hypertrophy treatment may include: […] Lifestyle changes. Heart-healthy habits can lower your blood pressure and reduce LVH complications. Good habits include eating healthy foods and being physically active. […] Blood pressure medication. Lowering your blood pressure will help prevent left ventricular hypertrophy from worsening. It also can reduce your risk of heart failure, heart attack or stroke. […] Other medicines. An SGLT2 inhibitor (an oral diabetes medicine) or allopurinol can help manage LVH. […] Heart valve surgery. If aortic valve stenosis caused your condition, you may need aortic valve surgery to replace the narrowed valve. This allows blood to flow properly.
- #17 Managing Hypertrophic Cardiomyopathyhttps://www.uspharmacist.com/article/managing-hypertrophic-cardiomyopathy
Pharmacologic treatment of symptomatic hypertrophic cardiomyopathy includes beta-blockers and nondihydropyridine calcium channel blockers. […] In symptomatic HCM, goals of therapy include alleviating exertional dyspnea, palpitations, and chest discomfort. Beta-blockers and nondihydropyridine (non-DHP) calcium channel blockers are the mainstay of therapy. […] Beta-blockers are recommended as first-line drug therapy in both obstructive and nonobstructive symptomatic HCM. […] Non-DHP calcium channel blockers are recommended in both obstructive and nonobstructive symptomatic HCM patients who do not respond to beta-blockers or who have adverse effects from or contraindications to beta-blockers. […] Disopyramide, a class Ia antiarrhythmic, is recommended in patients with obstructive HCM who remain symptomatic despite the use of beta-blockers and calcium channel blockers, alone or in combination.
- #18 Hypertrophic Cardiomyopathy: Causes, Symptoms & Treatmentshttps://my.clevelandclinic.org/health/diseases/17116-hypertrophic-cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a disease that causes your heart muscle to enlarge (hypertrophy). Most people who have it can have a normal life, but it can be serious for some people. If this is the case for you, there are several treatment options. […] The goal of your treatment is to minimize or prevent symptoms and reduce the risk of complications, such as heart failure and sudden cardiac death. […] Treatment can include: Risk identification and regular follow-up. Lifestyle changes. Medications. Procedures. […] Healthcare providers often prescribe medications to treat your symptoms and prevent further complications. Medications such as beta blockers and calcium channel blockers relax the heart muscle, allowing it to fill better and pump more effectively. Other medications can help control your heart rate or decrease the occurrence of arrhythmias.
- #19 Managing Hypertrophic Cardiomyopathyhttps://www.uspharmacist.com/article/managing-hypertrophic-cardiomyopathy
Pharmacologic treatment of symptomatic hypertrophic cardiomyopathy includes beta-blockers and nondihydropyridine calcium channel blockers. […] In symptomatic HCM, goals of therapy include alleviating exertional dyspnea, palpitations, and chest discomfort. Beta-blockers and nondihydropyridine (non-DHP) calcium channel blockers are the mainstay of therapy. […] Beta-blockers are recommended as first-line drug therapy in both obstructive and nonobstructive symptomatic HCM. […] Non-DHP calcium channel blockers are recommended in both obstructive and nonobstructive symptomatic HCM patients who do not respond to beta-blockers or who have adverse effects from or contraindications to beta-blockers. […] Disopyramide, a class Ia antiarrhythmic, is recommended in patients with obstructive HCM who remain symptomatic despite the use of beta-blockers and calcium channel blockers, alone or in combination.
- #20 Managing Hypertrophic Cardiomyopathyhttps://www.uspharmacist.com/article/managing-hypertrophic-cardiomyopathy
Pharmacologic treatment of symptomatic hypertrophic cardiomyopathy includes beta-blockers and nondihydropyridine calcium channel blockers. […] In symptomatic HCM, goals of therapy include alleviating exertional dyspnea, palpitations, and chest discomfort. Beta-blockers and nondihydropyridine (non-DHP) calcium channel blockers are the mainstay of therapy. […] Beta-blockers are recommended as first-line drug therapy in both obstructive and nonobstructive symptomatic HCM. […] Non-DHP calcium channel blockers are recommended in both obstructive and nonobstructive symptomatic HCM patients who do not respond to beta-blockers or who have adverse effects from or contraindications to beta-blockers. […] Disopyramide, a class Ia antiarrhythmic, is recommended in patients with obstructive HCM who remain symptomatic despite the use of beta-blockers and calcium channel blockers, alone or in combination.
- #21 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Evaluation usually can be conducted on an outpatient basis. Inpatient studies and surgical treatment also may be necessary. Medical and surgical therapy are used to reduce ventricular contractility or increase ventricular volume, increase ventricular compliance and outflow tract dimensions, and, in the case of obstructive hypertrophic cardiomyopathy (HCM), reduce the pressure gradient across the LV outflow tract. Paramount to any therapy is reduction in the risk of sudden death by identification of these patients early on and effective medical and/or surgical implantation of an automatic defibrillator. […] Medications include beta blockers, calcium channel blockers, and, rarely, diltiazem, amiodarone, and disopyramide. […] Mavacamten, a first-in-class allosteric inhibitor of cardiac myosin, gained approval from the FDA for adults with symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve exercise capacity and symptoms.
- #22 Left ventricular hypertrophy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/diagnosis-treatment/drc-20374319
Left ventricular hypertrophy that is caused by aortic valve stenosis might require a catheter procedure or surgery to repair or replace the valve. […] Surgery may be done if the condition causes heart failure symptoms or a blockage that interferes with the heart’s pumping action. […] Together you and your care team can develop a treatment plan that’s best for you.
- #23 Left Ventricular Hypertrophy (LVH)https://my.clevelandclinic.org/health/diseases/21883-left-ventricular-hypertrophy
Treating the cause of LVH will help stop or slow disease progression. Depending on the cause, you may need to change your daily habits, take medicine or have surgery. […] Left ventricular hypertrophy treatment may include: […] Lifestyle changes. Heart-healthy habits can lower your blood pressure and reduce LVH complications. Good habits include eating healthy foods and being physically active. […] Blood pressure medication. Lowering your blood pressure will help prevent left ventricular hypertrophy from worsening. It also can reduce your risk of heart failure, heart attack or stroke. […] Other medicines. An SGLT2 inhibitor (an oral diabetes medicine) or allopurinol can help manage LVH. […] Heart valve surgery. If aortic valve stenosis caused your condition, you may need aortic valve surgery to replace the narrowed valve. This allows blood to flow properly.
- #24 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] Surgical aortic valve replacement (SAVR) has been associated with regression of LVH, improvement in LV pressure, mass-to-volume ratios, EF, and heart failure symptomatology. […] Risk factor management includes an abundance of data from previous studies, but is not within the scope of this review. […] In patients with HCM who develop systolic dysfunction with an LVEF50%, guideline-directed therapy for heart failure with reduced EF is recommended.
- #25 Left Ventricular Hypertrophy | CardioVascular Health Clinicsearchenvelope-oexclamation-circlechevron-downlinkedin-squarephonefacebookuser-mdinstagramcrossmenuhttps://cvhealthclinic.com/conditions-treated/left-ventricular-hypertrophy/
Left ventricular hypertrophy is a common contributor to potentially serious heart complications, affecting an estimated 15% of the United States population. […] Addressing the primary cause of left ventricular hypertrophy can slow or stop the development of the disease. A variety of treatment options could be appropriate based on the cause, which might include: […] Blood pressure medication: Reducing your blood pressure will help keep the disease from progressing. Maintaining blood pressure at a safe level can minimize your risk of potentially dangerous conditions, including heart attack and stroke. […] Surgical intervention: When left ventricular hypertrophy results from aortic valve stenosis, aortic valve surgery might be required. The procedure repairs the blocked valve, permitting proper blood flow. […] Lifestyle changes: If your lifestyle contributes to your high blood pressure and narrowed arteries, adopting healthy habits could significantly reduce your risk of life-threatening complications. A heart-healthy diet combined with regular exercise is crucial to managing cardiovascular disease.
- #26 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Left ventricular (LV) myomectomy is used for patients with severe symptoms refractory to therapy and an outflow gradient of more than 50 mmHg, either with provocation or with rest. The procedure typically is successful in abolishing the outflow gradient; most patients have symptomatic improvement for at least 5 years. […] Pacemaker implantation has been a proposed treatment for patients with hypertrophic cardiomyopathy (HCM). Studies have shown that pacing the right ventricular (RV) apex to maintain atrioventricular synchrony results in a decrease of the left ventricular outflow tract (LVOT) gradient, with symptomatic and quality-of-life improvements. […] Transvenous catheter ablation of the septal region has been performed using selective arterial ethanol infusion to destroy myocardial tissue.
- #27 Hypertrophic Cardiomyopathy: Causes, Symptoms & Treatmentshttps://my.clevelandclinic.org/health/diseases/17116-hypertrophic-cardiomyopathy
Procedures for the treatment of hypertrophic obstructive cardiomyopathy include: Septal myectomy. During a septal myectomy, your surgeon removes a small amount of your thickened septal wall to widen the path your blood takes (outflow tract) from your left ventricle to your aorta. […] Ethanol ablation. This procedure, also called septal ablation, is reserved for people who cant have a septal myectomy. […] ICDs can help people at risk for life-threatening arrhythmias or sudden cardiac death. The ICD is a small device placed just under your skin and is connected to wire leads that are threaded through the vein to your heart. […] There are several ways to manage heart failure, from making lifestyle changes to medications that relieve symptoms or help the muscle in your heart to work the way it should.
- #28 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Left ventricular (LV) myomectomy is used for patients with severe symptoms refractory to therapy and an outflow gradient of more than 50 mmHg, either with provocation or with rest. The procedure typically is successful in abolishing the outflow gradient; most patients have symptomatic improvement for at least 5 years. […] Pacemaker implantation has been a proposed treatment for patients with hypertrophic cardiomyopathy (HCM). Studies have shown that pacing the right ventricular (RV) apex to maintain atrioventricular synchrony results in a decrease of the left ventricular outflow tract (LVOT) gradient, with symptomatic and quality-of-life improvements. […] Transvenous catheter ablation of the septal region has been performed using selective arterial ethanol infusion to destroy myocardial tissue.
- #29 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Alcohol septal ablation offers some advantages over surgical myectomy in that (1) it does not require surgical incision and/or general anesthesia, (2) the recovery time is shorter, and (3) its results lead to less discomfort and greater patient satisfaction than are reported with surgical myectomy. […] Sudden cardiac death occurs in approximately 1% of patients with hypertrophic cardiomyopathy (HCM) each year, and pharmacotherapy has not shown protection against sudden cardiac death. However, high-risk individuals in whom prophylactic therapy may be indicated may potentially benefit from placement of an implantable cardioverter defibrillator (ICD), which can effectively terminate life-threatening ventricular tachyarrhythmias in the setting of HCM. […] Heart transplantation is recommended in specific situations for patients with hypertrophic cardiomyopathy (HCM). The 2011 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines indications for heart transplantation include advanced heart disease and New York Heart Association (NYHA) functional class III or IV symptoms that are refractory to all other interventions.
- #30 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Alcohol septal ablation offers some advantages over surgical myectomy in that (1) it does not require surgical incision and/or general anesthesia, (2) the recovery time is shorter, and (3) its results lead to less discomfort and greater patient satisfaction than are reported with surgical myectomy. […] Sudden cardiac death occurs in approximately 1% of patients with hypertrophic cardiomyopathy (HCM) each year, and pharmacotherapy has not shown protection against sudden cardiac death. However, high-risk individuals in whom prophylactic therapy may be indicated may potentially benefit from placement of an implantable cardioverter defibrillator (ICD), which can effectively terminate life-threatening ventricular tachyarrhythmias in the setting of HCM. […] Heart transplantation is recommended in specific situations for patients with hypertrophic cardiomyopathy (HCM). The 2011 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines indications for heart transplantation include advanced heart disease and New York Heart Association (NYHA) functional class III or IV symptoms that are refractory to all other interventions.
- #31 Left Ventricular Hypertrophy (LVH)https://my.clevelandclinic.org/health/diseases/21883-left-ventricular-hypertrophy
Implantable cardioverter defibrillator (ICD). This device can shock your heart when you have certain abnormal heart rhythms. This treats a complication of LVH. […] Bariatric surgery. Surgery for weight loss can lower your weight and blood pressure. Lowering your blood pressure can keep LVH from getting worse.
- #32 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Left ventricular (LV) myomectomy is used for patients with severe symptoms refractory to therapy and an outflow gradient of more than 50 mmHg, either with provocation or with rest. The procedure typically is successful in abolishing the outflow gradient; most patients have symptomatic improvement for at least 5 years. […] Pacemaker implantation has been a proposed treatment for patients with hypertrophic cardiomyopathy (HCM). Studies have shown that pacing the right ventricular (RV) apex to maintain atrioventricular synchrony results in a decrease of the left ventricular outflow tract (LVOT) gradient, with symptomatic and quality-of-life improvements. […] Transvenous catheter ablation of the septal region has been performed using selective arterial ethanol infusion to destroy myocardial tissue.
- #33 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Alcohol septal ablation offers some advantages over surgical myectomy in that (1) it does not require surgical incision and/or general anesthesia, (2) the recovery time is shorter, and (3) its results lead to less discomfort and greater patient satisfaction than are reported with surgical myectomy. […] Sudden cardiac death occurs in approximately 1% of patients with hypertrophic cardiomyopathy (HCM) each year, and pharmacotherapy has not shown protection against sudden cardiac death. However, high-risk individuals in whom prophylactic therapy may be indicated may potentially benefit from placement of an implantable cardioverter defibrillator (ICD), which can effectively terminate life-threatening ventricular tachyarrhythmias in the setting of HCM. […] Heart transplantation is recommended in specific situations for patients with hypertrophic cardiomyopathy (HCM). The 2011 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines indications for heart transplantation include advanced heart disease and New York Heart Association (NYHA) functional class III or IV symptoms that are refractory to all other interventions.
- #34 Left Ventricular Hypertrophy (LVH)https://my.clevelandclinic.org/health/diseases/21883-left-ventricular-hypertrophy
Treating the cause of LVH will help stop or slow disease progression. Depending on the cause, you may need to change your daily habits, take medicine or have surgery. […] Left ventricular hypertrophy treatment may include: […] Lifestyle changes. Heart-healthy habits can lower your blood pressure and reduce LVH complications. Good habits include eating healthy foods and being physically active. […] Blood pressure medication. Lowering your blood pressure will help prevent left ventricular hypertrophy from worsening. It also can reduce your risk of heart failure, heart attack or stroke. […] Other medicines. An SGLT2 inhibitor (an oral diabetes medicine) or allopurinol can help manage LVH. […] Heart valve surgery. If aortic valve stenosis caused your condition, you may need aortic valve surgery to replace the narrowed valve. This allows blood to flow properly.
- #35 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
Determining the etiologies of left ventricular hypertrophy (LVH) can be challenging due to the similarities of the different manifestations in clinical presentation and morphological features. […] Management of LVH involves lifestyle changes, medications, surgery, and implantable devices. […] Treatment involves lifestyle changes (including weight reduction and exercise) and, depending upon the cause, may include medications, surgery, and implantable devices for the prevention of sudden cardiac death. […] Lowering the blood pressure with antihypertensive agents decreases cardiac mass in patients with LVH, and weight loss or dietary sodium restriction have additional beneficial effects on the improvement in cardiac mass. […] Numerous treatment strategies, ranging from thiazide diuretics, renin-angiotensinaldosterone system (RAAS) inhibitors and calcium channel blockers (CCBs) to sodium-glucose cotransporter type-2 (SGLT2) inhibitors have been shown to regress LVH.
- #36 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #37 Blood Pressure Control, Left Ventricular Hypertrophy and Treatment Pra | IJGMhttps://www.dovepress.com/blood-pressure-control-left-ventricular-hypertrophy-and-treatment-prac-peer-reviewed-fulltext-article-IJGM
Blood pressure (BP) control is an ultimate therapeutic goal of hypertensive patients in reducing early complications of hypertension. […] A further marker of early hypertension complications is LVH. […] The success of treating hypertension has been limited, and despite well-established approaches for diagnosis and treatment, in many communities, fewer than a half of all hypertensive patients have controlled blood pressure. […] Therefore, tailored interventions targeting BP control to reduce the magnitude of LVH and other early complications of hypertension deemed to be compulsory. […] Poor adherence to anti-hypertension medications and salt reduction, and being on triple anti-hypertensive drug therapy were found to be predictors of uncontrolled hypertension. […] The findings of the current study showed that participants with poor adherence to salt reduction in their meal were more than 8 times more likely to have uncontrolled blood pressure than those who reduced salt.
- #38 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #39 Blood Pressure Control, Left Ventricular Hypertrophy and Treatment Pra | IJGMhttps://www.dovepress.com/blood-pressure-control-left-ventricular-hypertrophy-and-treatment-prac-peer-reviewed-fulltext-article-IJGM
The number of antihypertensive drugs used in the treatment of hypertension plays a big role in hypertension control. […] The results of this study showed that the participants who were on three-drug combinations were seven times more likely to have uncontrolled hypertension than those on monotherapy while two drug combinations were a referent. […] The prevalence of LVH based on ECG findings is variable. […] Uncontrolled hypertension was found to have significant association with LVH. Participants with uncontrolled hypertension were more likely to develop LVH as compared to those with controlled hypertension. […] The result of this study has shown that abdominal obesity was significantly associated with LVH. Participants with abdominal obesity increase their odds to have LVH compared to participants who had no abdominal obesity. […] Therefore, early detection of LVH and aggressive lowering of BP can help to decrease these complications.
- #40 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #41 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #42 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #43 Left ventricular hypertrophy – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutubehttps://www.augustahealth.com/disease/left-ventricular-hypertrophy/
Treatment of sleep apnea. If youâve already been diagnosed with sleep apnea, treating this sleep disorder may lower your blood pressure and help reverse left ventricular hypertrophy if itâs caused by high blood pressure. […] Lifestyle changes can help lower your blood pressure, boost your heart health and improve left ventricular hypertrophy signs if caused by high blood pressure. Your doctor is likely to recommend heart-healthy lifestyle changes, including the following:
- #44 Left Ventricular Hypertrophy: Causes, Symptoms, and Treatmenthttps://www.medicoverhospitals.in/diseases/left-ventricular-hypertrophy/
The treatment for LVH focuses on addressing the underlying cause and managing symptoms. Here are some common treatment options: […] Making lifestyle changes can significantly impact the progression of LVH. These include: […] Several medications can help manage LVH and its underlying causes: […] In severe cases, surgical intervention may be necessary. Options include: […] Treating underlying conditions like diabetes or thyroid disorders can also help manage LVH effectively. […] Treatment includes managing underlying conditions with medications, lifestyle changes, and in some cases, surgery.
- #45 Left Ventricular Hypertrophy: Causes, Symptoms, and Treatmenthttps://www.medicoverhospitals.in/diseases/left-ventricular-hypertrophy/
The treatment for LVH focuses on addressing the underlying cause and managing symptoms. Here are some common treatment options: […] Making lifestyle changes can significantly impact the progression of LVH. These include: […] Several medications can help manage LVH and its underlying causes: […] In severe cases, surgical intervention may be necessary. Options include: […] Treating underlying conditions like diabetes or thyroid disorders can also help manage LVH effectively. […] Treatment includes managing underlying conditions with medications, lifestyle changes, and in some cases, surgery.
- #46 Left Ventricular Hypertrophy: Causes, Symptoms, and Treatmenthttps://www.medicoverhospitals.in/diseases/left-ventricular-hypertrophy/
The treatment for LVH focuses on addressing the underlying cause and managing symptoms. Here are some common treatment options: […] Making lifestyle changes can significantly impact the progression of LVH. These include: […] Several medications can help manage LVH and its underlying causes: […] In severe cases, surgical intervention may be necessary. Options include: […] Treating underlying conditions like diabetes or thyroid disorders can also help manage LVH effectively. […] Treatment includes managing underlying conditions with medications, lifestyle changes, and in some cases, surgery.
- #47 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
Starting early treatment while providing the appropriate target blood pressure prevents irreversible LVH. […] Apart from LIFE study, different angiotensin II receptor blockers (ARBs) have shown comparable benefit over beta adrenergic blockers. […] SGLT2 inhibitors are relatively novel antidiabetic agents with added benefits in terms of blood pressure and weight reduction. […] The association of LVH with increased cardiovascular morbidity and mortality demands aggressive treatment. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications.
- #48 Left Ventricular Hypertrophy: Etiology-Based Therapeutic Optionshttps://pmc.ncbi.nlm.nih.gov/articles/PMC9135932/
The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] The treatment of patients with Fabry disease primarily focuses upon replacing the missing or deficient enzyme (alpha-Gal A) with enzyme replacement therapy (ERT) as well as treating the various symptoms and disease complications. […] Surgical aortic valve replacement (SAVR) has been associated with regression of LVH, improvement in LV pressure, mass-to-volume ratios, EF, and heart failure symptomatology. […] Risk factor management includes an abundance of data from previous studies, but is not within the scope of this review. […] In patients with HCM who develop systolic dysfunction with an LVEF50%, guideline-directed therapy for heart failure with reduced EF is recommended.
- #49 Left ventricular hypertrophy – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutubehttps://www.augustahealth.com/disease/left-ventricular-hypertrophy/
If left ventricular hypertrophy is caused by high blood pressure, treating high blood pressure can help ease your symptoms and may reverse left ventricular hypertrophy. […] Blood pressure medication may help prevent further enlargement of the left ventricle and even shrink your hypertrophic muscles. Your doctor might recommend medications including: […] Left ventricular hypertrophy that is caused by aortic valve stenosis might require surgery to repair the narrow valve or to replace it with an artificial or tissue valve. […] Hypertrophic cardiomyopathy treatment. Left ventricular hypertrophy due to hypertrophic cardiomyopathy may be treated with medication, a nonsurgical procedure, surgery, implanted devices and lifestyle changes. […] Treatment for amyloidosis includes medications, chemotherapy and possibly a stem cell transplant. Treatment for amyloidosis is available at specialized clinics.
- #50 Effective Left Ventricular Hypertrophy Treatment Options – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Grouphttps://www.acibademhealthpoint.com/effective-left-ventricular-hypertrophy-treatment-options/
Regular heart check-ups are key to handling LVH. These visits include detailed cardiac function evaluation. This lets doctors see how the heart changes over time. […] Checking blood pressure often is key for hypertension management, which helps control LVH. Taking readings every day lets doctors spot changes early. […] Scientists are working hard to find new ways to treat Left Ventricular Hypertrophy (LVH). They are making big steps forward with research advancements. This brings hope to people who need help. […] To prevent LVH, eat well, stay active, and manage stress. Avoid too much alcohol and keep blood pressure under control. Regular health checks and preventive care are also key.
- #51 Effective Left Ventricular Hypertrophy Treatment Options – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Grouphttps://www.acibademhealthpoint.com/effective-left-ventricular-hypertrophy-treatment-options/
Regular heart check-ups are key to handling LVH. These visits include detailed cardiac function evaluation. This lets doctors see how the heart changes over time. […] Checking blood pressure often is key for hypertension management, which helps control LVH. Taking readings every day lets doctors spot changes early. […] Scientists are working hard to find new ways to treat Left Ventricular Hypertrophy (LVH). They are making big steps forward with research advancements. This brings hope to people who need help. […] To prevent LVH, eat well, stay active, and manage stress. Avoid too much alcohol and keep blood pressure under control. Regular health checks and preventive care are also key.
- #52 Effective Left Ventricular Hypertrophy Treatment Options – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Grouphttps://www.acibademhealthpoint.com/effective-left-ventricular-hypertrophy-treatment-options/
Regular heart check-ups are key to handling LVH. These visits include detailed cardiac function evaluation. This lets doctors see how the heart changes over time. […] Checking blood pressure often is key for hypertension management, which helps control LVH. Taking readings every day lets doctors spot changes early. […] Scientists are working hard to find new ways to treat Left Ventricular Hypertrophy (LVH). They are making big steps forward with research advancements. This brings hope to people who need help. […] To prevent LVH, eat well, stay active, and manage stress. Avoid too much alcohol and keep blood pressure under control. Regular health checks and preventive care are also key.
- #53https://link.springer.com/article/10.1007/s11936-999-0038-0
The purpose of serial echocardiographic studies in patients already being treated for hypertension is to ensure that LV geometry has not worsened and that function is unchanged or improved (especially with respect to previously noted diastolic Doppler inflow abnormalities). Considerable changes in estimated LV mass (60 g on serial intrapatient evaluation) are needed before the clinician can conclude with confidence that LV mass has decreased. […] More specific definitive recommendations based on the outcomes of current large-scale clinical trials are awaited.
- #54 I have had borderline LVH and anxiety for two years. What to do?https://www.icliniq.com/qa/left-ventricular-hypertrophy/how-can-i-manage-my-lvh-along-with-the-anxiety-issues
No need to worry; this is just a compensatory change in the heart in response to high blood pressure. It is similar to how bicep muscles hypertrophy in response to exercise. It will gradually improve as your blood pressure comes under control over time. Our primary focus is not on the LVH (left ventricular hypertrophy), as it typically does not create future problems. Instead, our target is to lower your blood pressure, which is the underlying cause, and you are already taking medication for it. So, it is essential to monitor your blood pressure regularly and keep it in check. […] I suggest the following treatment plan: […] Consider getting an ECG (echocardiogram) done to rule out any cardiac causes of chest discomfort.
- #55 Left Ventricular Hypertrophy: Risk Factors, Symptoms, and Treatmenthttps://www.healthline.com/health/left-ventricular-hypertrophy
Left ventricular hypertrophy (LVH) is when the hearts main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart condition and treating that condition may stop progression or reverse LVH. […] The most effective treatment of LVH is treating the condition that is causing the problem. For example, if high blood pressure has caused a thickening of the left ventricle, taking blood pressure-lowering drugs (antihypertensives) and making certain lifestyle changes may be sufficient. […] For aortic valve stenosis or other valve problems, the procedure to repair or replace the affected valve may help reduce the risk of further complications. […] Regardless of the cause of LVH and the treatment recommended by your doctor, everyone with the condition should manage the following heart-healthy behaviors: eating a balanced diet, such as the Mediterranean eating plan or the Dietary Approaches to Stop Hypertension (DASH) diet, exercising with at least 150 minutes of moderate-intensity aerobic activity, getting 7 to 9 hours of sleep each night, limiting alcohol consumption, managing stress. […] LVH can sometimes be reversed when the underlying condition is treated effectively. For others, changes to the left ventricle may be permanent. But a healthy, active life may be possible with lifelong care by a cardiologist and adherence to a heart-healthy lifestyle.
- #56 What Causes Left Ventricular Hypertrophy (LVH)?https://www.verywellhealth.com/left-ventricular-hypertrophy-8728481
Left ventricular hypertrophy (LVH) can usually be reduced or reversed by treating the underlying cause, which entails adopting healthy lifestyle behaviors and taking medication or undergoing surgery. […] Depending on the cause, LVH can be reduced or reversedâa term called LVH regression. For example, if LVH is caused by high blood pressure, lowering the blood pressure can lead to LVH regression. […] Similarly, if LVH is caused by a heart valve problem, like aortic stenosis, surgery to repair or replace the valve may be performed to achieve LVH regression and improve the heart’s functioning. […] Achieving LVH regression through medication or surgery decreases the risk of severe complications like heart attack and stroke. […] If you or a loved one has LVH, treatment is directed at managing or fixing the underlying cause. While medication and/or surgery may be indicated, adopting heart-healthy lifestyle behaviors also plays a key role.
- #57 Regression of left ventricular hypertrophy | Hypertension Researchhttps://www.nature.com/articles/s41440-024-01634-6
Studies have reported that improvements in LVH with hypertension treatment reduce cardiovascular events and sudden death. In the present study, LVH regression was associated with a decreased risk for the composite outcome of cardiovascular death and hospitalization for heart failure regardless of age, suggesting that LVH regression may be a marker of improved cardiovascular morbidity and prognosis even in elderly patients.
- #58 Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy | Hearthttps://heart.bmj.com/content/110/15/997
Enzyme replacement therapy (ERT) may halt or attenuate disease progression in patients with Anderson-Fabry disease (AFD). However, whether left ventricular hypertrophy (LVH) can be prevented by early therapy or may still progress despite ERT over a long-term follow-up is still unclear. […] Over a median follow-up of 10 years under ERT, 36% of the patients still had LVMI cardiac progression, and 32%, predominantly older men, experienced major AFD-related events. LVH at treatment initiation was a strong predictor of LVMI progression and adverse events on ERT. […] Current expert consensus recommends enzyme replacement therapy (ERT) initiation as soon as possible in men with the classic form of the disease, before organ involvement, and for women with the classic form and patients with late-onset form at the earliest signs of organ involvement.
- #59 Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy | Hearthttps://heart.bmj.com/content/110/15/997
Our findings show that LVMI continues to progress despite ERT in a significant proportion of patients with baseline LVH. […] The only independent predictor of cardiac progression over the extended FU was the presence of LVH at the first ERT infusion. This is of most clinical relevance since the current expert consensus recommends ERT initiation in all patients at the earliest signs of organ involvement.
- #60 Effective Left Ventricular Hypertrophy Treatment Options – Acibadem Health Point – ACIBADEM Hospitals – Acibadem Health Grouphttps://www.acibademhealthpoint.com/effective-left-ventricular-hypertrophy-treatment-options/
Regular heart check-ups are key to handling LVH. These visits include detailed cardiac function evaluation. This lets doctors see how the heart changes over time. […] Checking blood pressure often is key for hypertension management, which helps control LVH. Taking readings every day lets doctors spot changes early. […] Scientists are working hard to find new ways to treat Left Ventricular Hypertrophy (LVH). They are making big steps forward with research advancements. This brings hope to people who need help. […] To prevent LVH, eat well, stay active, and manage stress. Avoid too much alcohol and keep blood pressure under control. Regular health checks and preventive care are also key.
- #61 Regression of left ventricular hypertrophy | Hypertension Researchhttps://www.nature.com/articles/s41440-024-01634-6
Left ventricular hypertrophy (LVH), which is frequently caused by pressure and volume overload, has typically been associated with several disorders such as hypertension and aortic stenosis. […] Although LVH had initially been considered irreversible, recent findings have shown otherwise. One study showed that although all major antihypertensive drugs regress LVH, treatment with angiotensin-converting-enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs) was also favorably associated with improvement in LVH. A recent meta-analysis comparing the effects of ARBs, ACE inhibitors, beta-blockers, CCBs, and diuretics on LVH regression showed that ARBs were the most effective antihypertensive agents. […] More recently, angiotensin receptor-neprilysin inhibitors have been reported to be effective in regressing hypertrophy. Moreover, sodium-glucose cotransporter-2 (SGLT2) inhibitors have been reported to reduce LV mass and ambulatory blood pressure and improve the prognosis of heart failure patients; however, their association with improved LVH warrants further investigation.
- #62 Regression of left ventricular hypertrophy | Hypertension Researchhttps://www.nature.com/articles/s41440-024-01634-6
Left ventricular hypertrophy (LVH), which is frequently caused by pressure and volume overload, has typically been associated with several disorders such as hypertension and aortic stenosis. […] Although LVH had initially been considered irreversible, recent findings have shown otherwise. One study showed that although all major antihypertensive drugs regress LVH, treatment with angiotensin-converting-enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs) was also favorably associated with improvement in LVH. A recent meta-analysis comparing the effects of ARBs, ACE inhibitors, beta-blockers, CCBs, and diuretics on LVH regression showed that ARBs were the most effective antihypertensive agents. […] More recently, angiotensin receptor-neprilysin inhibitors have been reported to be effective in regressing hypertrophy. Moreover, sodium-glucose cotransporter-2 (SGLT2) inhibitors have been reported to reduce LV mass and ambulatory blood pressure and improve the prognosis of heart failure patients; however, their association with improved LVH warrants further investigation.
- #63 Timing and Targeting of Treatment in Left Ventricular Hypertrophy | Methodist DeBakey Cardiovascular Jhttps://journal.houstonmethodist.org/articles/10.14797/mdcj-13-1-9
Targeting stress-induced transcriptional changes in the heart could be an effective new therapeutic strategy. […] Target choice in transcriptional control-based treatments requires consideration of both timing and target specificity and should be aimed at increasing molecular flexibility in the heart. […] In order to effectively target transcription for therapeutic use, we must better understand when these transcription changes start and how reversing them during cardiac stress, and not just before onset, affects the response.
- #64https://journals.lww.com/co-cardiology/fulltext/2024/07000/prevention_and_treatment_of_hypertensive_left.4.aspx
Left ventricular (LV) hypertrophy (LVH) is a well recognized target organ adaptation to longstanding uncontrolled hypertension and other cardiovascular risk factors. It is also a strong and independent predictor of many cardiovascular disorders. […] This focused review explores the current concepts in screening, diagnosis, prevention, and treatment of LVH in patients with hypertension. Currently, the primary screening and diagnostic tools for LVH are ECG and 2D echocardiography. Implementing machine learning in the diagnostic modalities can improve sensitivity in the detection of LVH. Lifestyle modifications, blood pressure control with antihypertensive therapy, and management of comorbidities aid in preventing and reversing LV remodeling. […] Prevention and reversal of LV remodeling are crucial for cardiovascular risk reduction in patients with hypertension.
- #65 Left ventricular hypertrophy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/diagnosis-treatment/drc-20374319
Left ventricular hypertrophy that is caused by aortic valve stenosis might require a catheter procedure or surgery to repair or replace the valve. […] Surgery may be done if the condition causes heart failure symptoms or a blockage that interferes with the heart’s pumping action. […] Together you and your care team can develop a treatment plan that’s best for you.
- #66 Left Ventricular Hypertrophy (LVH): Causes, Diagnosis & Treatments | MedStar Healthhttps://www.medstarhealth.org/services/left-ventricular-hypertrophy
Diagnosing left ventricular hypertrophy is the first step to developing a treatment plan. Your doctor may recommend one or more diagnostic and imaging procedures. […] Our heart and vascular teams work together and with other specialties to develop and implement individualized plans to treat LVH and any underlying conditions that are causing your heart to be overworked. Your treatment plan could include lifestyle modifications, medication, or more advanced treatments. […] Heart surgery is an option to treat many heart conditions. You may need heart surgery either as a lifesaving procedure or when other treatments haven’t worked.
- #67 Left ventricular hypertrophy // Middlesex Healthhttps://middlesexhealth.org/learning-center/diseases-and-conditions/left-ventricular-hypertrophy
Treatment of left ventricular hypertrophy depends on the cause. Treatment may include medications or surgery. […] Treatment for left ventricular hypertrophy depends on the underlying cause. It may include medications, catheter procedures or surgery. It’s important to manage conditions such as high blood pressure and sleep apnea, which can cause blood pressure to be higher. […] Medicines are used to treat symptoms and prevent complications of left ventricular hypertrophy. Blood pressure drugs may help reduce or prevent thickening of the heart muscle. The type of medication prescribed depends on the cause of left ventricular hypertrophy. […] Medications that might be used to treat left ventricular hypertrophy or the conditions that cause it include: Angiotensin-converting enzyme inhibitors. Also called ACE inhibitors, these medications widen blood vessels to lower blood pressure. They can improve blood flow and decrease the strain on the heart. Side effects include a persistent cough. […] Left ventricular hypertrophy that is caused by aortic valve stenosis might require a catheter procedure or surgery to repair or replace the valve. […] Surgery may be done if the condition causes heart failure symptoms or a blockage that interferes with the heart’s pumping action.
- #68 Hypertrophic Cardiomyopathy Treatment & Management: Approach Considerations, Left Ventricular Myomectomy and Mitral Valve Replacement, Pacemaker Implantationhttps://emedicine.medscape.com/article/152913-treatment
Evaluation usually can be conducted on an outpatient basis. Inpatient studies and surgical treatment also may be necessary. Medical and surgical therapy are used to reduce ventricular contractility or increase ventricular volume, increase ventricular compliance and outflow tract dimensions, and, in the case of obstructive hypertrophic cardiomyopathy (HCM), reduce the pressure gradient across the LV outflow tract. Paramount to any therapy is reduction in the risk of sudden death by identification of these patients early on and effective medical and/or surgical implantation of an automatic defibrillator. […] Medications include beta blockers, calcium channel blockers, and, rarely, diltiazem, amiodarone, and disopyramide. […] Mavacamten, a first-in-class allosteric inhibitor of cardiac myosin, gained approval from the FDA for adults with symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve exercise capacity and symptoms.
- #69https://link.springer.com/article/10.1007/s11936-999-0038-0
The use of ACE inhibitors is increasing. Unfortunately, the cost of these agents is higher than that of some other classes of agents, such as diuretics, which show excellent evidence of regression of hypertrophy. African-American and elderly persons, in particular, may benefit from diuretics for treatment of hypertension as well as reduction of left ventricular (LV) mass. […] Beta-blockers should be considered in the elderly, especially those with greatly thickened LV walls and small chamber sizes, factors associated with hyperdynamic systolic performance, systolic midcavity obliteration, and diastolic relaxation abnormalities on echocardiography. […] Calcium channel blockers may also be useful in patients with LVH who have normal systolic performance and diastolic compliance abnormalities.
- #70 Left Ventricular Hypertrophy: Causes, Symptoms, and Treatmenthttps://www.medicoverhospitals.in/diseases/left-ventricular-hypertrophy/
The treatment for LVH focuses on addressing the underlying cause and managing symptoms. Here are some common treatment options: […] Making lifestyle changes can significantly impact the progression of LVH. These include: […] Several medications can help manage LVH and its underlying causes: […] In severe cases, surgical intervention may be necessary. Options include: […] Treating underlying conditions like diabetes or thyroid disorders can also help manage LVH effectively. […] Treatment includes managing underlying conditions with medications, lifestyle changes, and in some cases, surgery.
- #71https://link.springer.com/article/10.1007/s11936-999-0038-0
The use of ACE inhibitors is increasing. Unfortunately, the cost of these agents is higher than that of some other classes of agents, such as diuretics, which show excellent evidence of regression of hypertrophy. African-American and elderly persons, in particular, may benefit from diuretics for treatment of hypertension as well as reduction of left ventricular (LV) mass. […] Beta-blockers should be considered in the elderly, especially those with greatly thickened LV walls and small chamber sizes, factors associated with hyperdynamic systolic performance, systolic midcavity obliteration, and diastolic relaxation abnormalities on echocardiography. […] Calcium channel blockers may also be useful in patients with LVH who have normal systolic performance and diastolic compliance abnormalities.
- #72 Left ventricular hypertrophy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/left-ventricular-hypertrophy/diagnosis-treatment/drc-20374319
Left ventricular hypertrophy that is caused by aortic valve stenosis might require a catheter procedure or surgery to repair or replace the valve. […] Surgery may be done if the condition causes heart failure symptoms or a blockage that interferes with the heart’s pumping action. […] Together you and your care team can develop a treatment plan that’s best for you.
- #73https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=abr9384
LVH is linked to an increased risk of other problems, including heart attack, heart failure, stroke, and heart rhythm problems. Treatment can help reduce these risks. […] The best treatment will depend on what caused LVH. For many people, the focus will be on treating high blood pressure. Getting high blood pressure under control may keep LVH from getting worse. This can help prevent heart failure. It can also help lower the risk of heart attack and stroke. […] If LVH was caused by a heart problem, you may have other treatment options. Treatment may help lower your risk of heart failure and other serious problems. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor or nurse advice line if you are having problems.